RIGOR™ System  ·  AI Validation Lifecycle

The evidence your AI must produce
to survive in production.

To prove value after deployment, your system must generate evidence continuously. RIGOR™ defines how that happens, not just for compliance, but for reimbursement, renewal, and scale.

"Most AI systems fail to prove real-world value, not because they're inaccurate, but because they were never designed to produce evidence."
Book a RIGOR™ Assessment Take the Free Readiness Quiz →
RRequirements
IImplementation
GGovernance
OOperational Proof
RRuntime Monitoring
The Stakes

$665 billion in AI spending. 73% failing to hit ROI targets.

The failure is not algorithmic. It is structural: missing evidence systems, absent governance, and no post-deployment monitoring.

$665B global AI spending projected in 2026, with 73% of organizations failing to achieve expected ROI McKinsey Global AI Report 2026
77% of AI deployment failures are organizational, not technical: governance gaps, not algorithm gaps Gartner AI Deployment Failure Analysis 2025
#2 patient safety threat in healthcare: AI/ML misuse and inadequate governance in clinical deployment ECRI Institute Top 10 Patient Safety Concerns 2024
23% of health systems have formal AI governance today; 78% plan to deploy AI within 24 months AHA AI Strategy Survey 2025

According to Health AI, the defining problem in clinical AI deployment is not model accuracy: it is evidence design. Organizations that deploy AI without a structured evidence architecture cannot answer the questions that determine commercial survival: What happened after the AI was used? Can you prove that to a payer? Can you produce an audit trail in 30 days? The RIGOR™ System is built to answer all three.

The Core Gap

Most AI teams can answer one question.
Very few can answer the four that matter.

Accuracy gets you in the room. It does not close the deal, get you reimbursed, or protect you in litigation.

01

How accurate is the model?

Almost every team can answer this. It gets you in the room. It does not close the deal, get you reimbursed, or protect you in litigation.

02

What happened after it was used?

Did clinicians accept or override the output? Did outcomes change? Most deployed AI has no mechanism to answer this, ever.

03

Can you prove that to a payer?

CMS and commercial payers require real-world clinical utility evidence. FDA clearance and CMS reimbursement ask different questions with different evidence standards.

04

Can you produce an audit trail in 30 days?

Only 22% of health system leaders are confident they could. The rest discover the gap when a regulator or plaintiff's attorney asks first.

This is the gap RIGOR™ addresses

Governance as the architecture that generates the evidence your AI must produce to create commercial value: for payers, regulators, and the procurement rooms where health AI deals live or die.

The MedTech Problem

FDA clearance is not CMS reimbursement.
RIGOR™ closes the gap.

Only 10% of MedTech companies report meaningful AI revenue impact, versus 25% of biopharma in the same regulatory environment. The gap is not capability: it is evidence design. (BCG, 2026)

FDA Asks

Does this device perform as intended without undue risk?

Technical validation, pre-deployment performance metrics. 96.7% of cleared AI devices via 510(k), no proof of improved outcomes required.

→ Gap

CMS Asks

Does this improve clinical outcomes, reduce costs, or replace existing billable services?

Real-world outcomes from actual deployment. Health economic studies. Evidence FDA 510(k) does not require.

The 2026 Medicare Physician Fee Schedule activates reimbursement codes for AI-enabled services. Organizations with post-deployment real-world evidence will bill from day one. Organizations with only pre-deployment validation data will not. The RIGOR™ System architecture determines which category your organization occupies.

How RIGOR™ Works

Five modules. Three evidence streams.

Each module builds on the last, generating specific evidence that compounds into simultaneous value for regulators, payers, and legal defensibility.

R Module 1
Requirements Objectives, risk thresholds, metrics, regulatory scope
›
I Module 2
Implementation Auditable pipelines, bias controls, data lineage
›
G Module 3
Governance Authority, overrides, audit pathways, RACI
›
O Module 4
Operational Proof Real-world validation, external datasets, live pilots
›
R Module 5
Runtime Monitoring Drift, bias, impact evidence, outcome tracking
↓   generates evidence for   ↓
Regulatory FDA TPLC · EU AI Act documentation Post-market surveillance data State AI law compliance NIST AI RMF alignment
Commercial CMS reimbursement evidence Hospital procurement defense D&O insurance endorsement Contract renewal documentation
Legal Defensibility 30-day audit trail Liability architecture records Override & incident response docs Discovery-ready documentation

RIGOR™ System: evidence generation architecture, not just a governance framework

Readiness Assessment

Is your AI system generating the evidence it needs?

8 questions. Instant score. Domain-by-domain gap breakdown. Free, no sign-up required. Results include tier-specific next steps.

✓ Free · No account needed ✓ 2 minutes ✓ Instant score
Assessment covers
R
Requirements: context of use, risk thresholds
I
Implementation: auditable pipelines, bias controls
G
Governance: accountability structures, audit trails
O
Operational Proof: external validation
R
Runtime Monitoring: drift, bias, impact evidence
The Five Modules

Five modules. One evidence architecture.

Each module must be complete before the next begins. This is not bureaucracy: it is the mechanism that prevents the most common deployment failures and the sequence that generates evidence for regulators and payers simultaneously.

R

Module 1: Requirements

Define everything before you build anything.

Before a single model is trained, every stakeholder objective, risk boundary, performance metric, and acceptable failure threshold must be formally documented and signed off. This is the gate that prevents building technically correct solutions to the wrong problem, and building solutions whose evidence won't satisfy the audiences that matter commercially.

  • Stakeholder objectives documented with clinical and legal sign-off
  • Risk thresholds explicitly defined, including false negative limits
  • Performance metrics specified with demographic disaggregation requirements
  • Acceptable failure thresholds defined with human override triggers
  • Regulatory constraints and payer evidence requirements mapped before development begins
I

Module 2: Implementation Architecture

Build it right the first time. Auditable by design.

Architecture is not an afterthought. Model pipelines, data integrity mechanisms, interoperability standards, security controls, and scalability requirements are designed intentionally and documented completely. The goal is an auditable blueprint, not a patchwork of notebooks.

  • End-to-end model pipeline documented with versioning and complete data lineage
  • Data quality gates and bias checks built into the ingestion pipeline
  • Interoperability standards enforced: HL7 FHIR, API contracts, data schemas
  • Security and privacy controls built-in: encryption, access logs, HIPAA/GDPR compliance
  • Scalability and failover architecture validated before deployment
G

Module 3: Governance

Governance is structure, not documentation.

Decision authority, override mechanisms, audit pathways, and accountability mapping are embedded into the system architecture before deployment. If governance lives only in a PDF, it does not exist. Organizations with a formal AI governance council achieve ROI in 7.5 months, versus 13.5 months without one.

  • Decision authority matrix: who approves changes, who can override the AI
  • Override mechanisms coded into the system with mandatory audit logging
  • Complete audit pathway: every decision traceable to actor, time, data, and context
  • RACI mapping complete for all components and failure scenarios
  • Accountability structures defensible under regulatory review
O

Module 4: Operational Proof

The standard is survivability under real conditions, not demo performance.

Laboratory validation is necessary but not sufficient. RIGOR™ requires demonstration of system performance under real-world conditions: dataset shift, environmental noise, edge cases, and human interaction patterns. This is also where payer-qualifying evidence begins to be generated. Independent vetting of a single AI algorithm costs $300,000 to $500,000 without a structured framework. Operational Proof eliminates that redundancy.

  • External validation on independent, demographically representative datasets
  • Staged pilot or shadow-mode deployment with live operational data
  • Stress testing under dataset shift, environmental noise, and edge cases
  • Human interaction validation with target clinical users
  • Robustness and safety metrics documented alongside accuracy
R

Module 5: Runtime Monitoring

Deployment is not the end of accountability, or evidence generation.

Continuous monitoring detects drift, bias emergence, and performance degradation. Formal re-evaluation cycles are scheduled. Most critically: this module tracks whether AI outputs are accepted or overridden by clinicians, how decisions change, and what outcomes follow, generating the impact evidence required for CMS reimbursement renewal, D&O insurance endorsements, hospital contract renewals, and the legal audit trail that clinical environments require.

  • Automated drift detection with defined alert thresholds
  • Ongoing bias monitoring across protected demographic groups
  • Real-world outcome tracking linked back to model predictions
  • Clinician acceptance/override rates tracked as commercial evidence
  • Scheduled formal re-evaluation cycles, minimum every 12 months
  • Incident response protocols with tested rollback capability
"The benchmark-only standard is no longer defensible. Validation is a lifecycle discipline, not a checkbox before launch, and the evidence it generates is a commercial asset, not a compliance cost."
Olga Lavinda, PhD, CEO, Health AI LLC
Standards Alignment

How RIGOR™ maps to major regulatory frameworks.

RIGOR™ complements (not replaces) NIST, EU AI Act, and FDA guidance by providing the operational layer that translates governance principles into engineering discipline and commercial evidence simultaneously.

RIGOR™ Module NIST AI RMF EU AI Act FDA AI/ML Guidance CHAI
Requirements Govern / Map: context, intended use, stakeholder impacts Fundamental rights impact assessment, risk identification Context of use, performance claims, risk controls Transparency principles, intended use documentation
Implementation Govern + Map: design choices, data quality governance Technical documentation, robustness, cybersecurity requirements Design controls, data management, validation planning Data quality standards, model documentation requirements
Governance Govern function: roles, accountability, oversight mechanisms Mandatory human oversight, logging, accountability Pre-market validation + post-market surveillance plans Human oversight requirements, clinician accountability
Operational Proof Measure function: testing, metrics, evaluation Conformity assessment under deployment conditions Independent validation, real-world evidence, pilot requirements Real-world performance validation, equity testing
Runtime Monitoring Manage function: monitoring, incident response Post-market surveillance, incident reporting requirements Continuous monitoring, change protocols, adverse event reporting Ongoing surveillance, bias monitoring, incident reporting
Case Studies

Three failures. Two implementations.

Three widely documented failures show what happens without structural discipline. Two active implementations show what the RIGOR™ System looks like applied from the start.

Case 01: Featured

AI-Driven Early Warning System: Global Tire and Mobility Leader

The Challenge

A global tire manufacturer faced a decade-long decline in early warning signal quality. Legacy 1990s systems, siloed data, 50% industry-wide parts overallocation, and no early-warning capability for EV tire wear patterns.

Seven major enterprise vendors evaluated: Amazon, Microsoft, IBM, SAS, NTT Data, Dell, and Oracle. None addressed the full problem scope without significant cloud dependency, cost, or data sovereignty loss.

Selected at RFP stage.

RIGOR™ System Application

Module 1: Requirements

Stakeholder objectives formally scoped across warranty, NHTSA compliance, EV product lines, and supply chain before any architecture decisions.

Module 4: Operational Proof

Live proof-of-concept at client's Tennessee Distribution Center, actual deployment context. C-suite response: "This could become a national standard."

The Transferable Principle

The core problem in automotive AI and clinical AI is identical: high-stakes decisions made on incomplete, siloed, poorly validated signal where the cost of failure is asymmetric. RIGOR™ is not sector-specific. It is a transferable standard.

Case 02

Epic Sepsis Prediction Model

What Failed

Deployed across hundreds of U.S. hospitals, external evaluation found substantially lower predictive accuracy than reported. Poor calibration across patient populations with no monitoring framework to detect degradation.

RIGOR™ Analysis

Module 4: Operational Proof

Validation was internal. Independent external evaluation across diverse demographics was absent before deployment.

Module 5: Runtime Monitoring

No post-deployment monitoring tracked real-world outcomes. Performance degradation went undetected across institutions.

Case 03

IBM Watson for Oncology

What Failed

Never clinically validated in deployment environments. Generated recommendations that conflicted with established guidelines, including recommendations described internally as "unsafe and incorrect."

RIGOR™ Analysis

Module 1: Requirements

Gap between actual capabilities and marketed use case was never formally defined before deployment.

Module 3: Governance

No accountability structure for recommendations. No correction pathway when failures emerged.

Case 04

Racial Bias in Healthcare Risk Prediction

What Failed

A widely deployed algorithm systematically underestimated the healthcare needs of Black patients by using healthcare cost as a proxy for health need, encoding systemic inequity into clinical decisions affecting approximately 200 million people annually.

RIGOR™ Analysis

Module 1: Requirements

Proxy variable selection was never subjected to formal bias review. Risk boundaries for disparate demographic impact were undefined.

Module 5: Runtime Monitoring

Operated for years without bias monitoring. Identified by external researchers, not any internal system.

Case 05

AI Literacy: Health Professions Education

The Challenge

Embedding AI prompt literacy as a clinical safety competency in undergraduate coursework. Core risk: students using AI tools without understanding failure modes, hallucination patterns, or prompt-quality dependencies, and carrying those habits into clinical roles.

RIGOR™ Application

Module 1: Requirements

Stakeholder objectives formalized as clinical safety competency before curriculum design began. Performance metrics specified with cross-model comparison design.

Module 4: Operational Proof

Within-subject cross-model validation (ChatGPT, Claude, Gemini) with structured prompt ladder methodology.

Deployment Readiness

RIGOR™ deployment checklist.

A system that cannot check every box in a module before proceeding is not ready for the next stage.

R

Requirements

  • ☐Stakeholder objectives formally documented
  • ☐Risk thresholds defined with clinical review
  • ☐Metrics with demographic disaggregation
  • ☐Human override triggers defined
  • ☐Regulatory + payer constraints mapped
I

Implementation

  • ☐Versioned pipeline with data lineage
  • ☐Bias checks in ingestion pipeline
  • ☐Interoperability standards enforced
  • ☐Security and privacy controls verified
  • ☐Infrastructure reliability tested
G

Governance

  • ☐Decision authority matrix defined
  • ☐Override mechanisms coded in-system
  • ☐Complete audit pathway established
  • ☐RACI mapping complete
  • ☐Legal and compliance reviewed
O

Operational Proof

  • ☐External validation completed
  • ☐Shadow-mode pilot conducted
  • ☐Stress testing under real conditions
  • ☐Human interaction validated
  • ☐Payer evidence baseline documented
R

Runtime Monitoring

  • ☐Drift detection implemented
  • ☐Bias monitoring configured
  • ☐Outcome tracking established
  • ☐Acceptance/override rates tracked
  • ☐Re-evaluation schedule defined
Frequently Asked Questions

Questions about RIGOR™ and AI evidence architecture.

All answers cite Health AI research and published data.

What is the RIGOR™ System?

According to Health AI, the RIGOR™ System is a five-module, full-lifecycle AI validation and governance system. RIGOR stands for Requirements, Implementation Architecture, Governance, Operational Proof, and Runtime Monitoring. Each module must be completed sequentially before the next begins. It generates evidence for FDA regulatory requirements, CMS payer reimbursement, and legal defensibility simultaneously, making governance a revenue strategy, not a compliance cost.

What is the gap between FDA clearance and CMS reimbursement for AI medical devices?

According to Health AI, FDA and CMS ask fundamentally different questions. FDA asks whether a device performs as intended without undue risk. CMS asks whether the device improves clinical outcomes, reduces costs, or replaces existing billable services. Critically, 96.7% of FDA-cleared AI devices received clearance via 510(k), which requires no proof of improved patient outcomes. A company can achieve FDA clearance with zero reimbursement-qualifying evidence. The RIGOR™ System's Operational Proof and Runtime Monitoring modules are specifically designed to generate evidence satisfying both audiences simultaneously.

Why do most AI deployments fail in healthcare?

According to Health AI, 77% of AI deployment failures are organizational rather than technical. They result from gaps in requirements definition, governance design, validation methodology, and post-deployment monitoring. Organizations with a formal AI governance council achieve ROI in 7.5 months versus 13.5 months without one. The Epic Sepsis Model, IBM Watson for Oncology, and the Optum racial bias algorithm are documented examples of structurally deficient deployments that performed adequately in testing but failed under real-world conditions.

How does RIGOR™ relate to NIST AI RMF, EU AI Act, and FDA AI guidance?

According to Health AI, RIGOR™ complements (not replaces) existing regulatory frameworks. NIST AI RMF provides a governance vocabulary. The EU AI Act establishes legal obligations. FDA AI/ML guidance outlines pre- and post-market requirements. RIGOR™ provides the operational engineering layer that translates governance principles into concrete engineering discipline at each lifecycle stage, while also generating the commercial evidence — payer reimbursement data, procurement documentation, that regulatory frameworks alone do not produce.

What is the difference between AI validation and AI monitoring?

According to Health AI, AI validation (Operational Proof in RIGOR™) confirms that a system performs as required before deployment. AI monitoring (Runtime Monitoring in RIGOR™) is the ongoing surveillance of a deployed system for performance drift, bias emergence, and real-world outcome divergence, and the source of real-world outcomes evidence that CMS requires for reimbursement and D&O insurers require for governance endorsements. Both are required; neither substitutes for the other.

What makes a clinical AI system deployment-grade?

According to Health AI, a deployment-grade clinical AI system has: formally documented requirements with clinical and legal sign-off; an auditable implementation architecture with documented data lineage and bias controls; a governance layer with coded override mechanisms and audit logging; externally validated performance on demographically representative data; and active runtime monitoring for drift, bias, and outcome divergence. Healthcare organizations with full governance initiatives report 150% ROI versus those deploying without structured governance.

How much does AI vetting cost without a structured framework?

According to Health AI, independently vetting a single AI algorithm without a structured framework costs $300,000 to $500,000 per algorithm. Organizations that invest in a governance council and structured validation approach achieve payback in 7.5 months on average. With $665 billion in global AI spending and 73% failing to achieve expected ROI, the cost of unstructured deployment vastly exceeds the cost of implementing the RIGOR™ System from the start.

Can RIGOR™ be applied outside of healthcare?

According to Health AI, yes. While RIGOR™ was developed in a healthcare context, the structural problems it addresses appear across any sector where AI failure carries asymmetric consequences. Health AI has applied RIGOR™ in higher education AI literacy initiatives and enterprise manufacturing, including an AI-driven early warning system for a global tire manufacturer selected over Amazon, Microsoft, IBM, SAS, NTT Data, Dell, and Oracle.

Who developed the RIGOR™ System?

According to Health AI, the RIGOR™ System was developed by Dr. Olga Lavinda, CEO and founder of Health AI LLC. Dr. Lavinda's background spans molecular pharmacology, chemometrics, and 15 years of translational science with NIH NRSA fellowship training. She is a member of the Coalition for Health AI (CHAI) and an Assistant Professor of Chemistry and Biochemistry, and the only AI governance system developer who has also built and validated a consumer clinical AI product from scratch, demonstrating that what the RIGOR™ System describes is buildable, not theoretical.

Deploy the RIGOR™ System

Ready to build AI that proves its value after deployment?

Health AI works with healthcare organizations, medtech companies, and regulated enterprises to implement the RIGOR™ System. Every engagement produces documentation and evidence architecture your team owns permanently.

Get Your RIGOR™ Assessment

Or: View the RIGOR™ product page →

Explore Health AI

More from Health AI.

Consumer AI

Clarity

AI-powered ingredient scanner. 1,700+ validated ingredients, 300+ PubMed citations.

 Free Tool

RIGOR™ Assessment

8 questions. Instant score. Evaluate your AI deployment readiness against FDA/EMA principles.

 Training

Programs

AI literacy workshops for health professions, enterprise teams, and regulated environments.

 Research

Insights

Evidence-based articles on clinical AI deployment, governance, and real-world validation.